Asia healthcare assets risk overvaluation as private investors scoop them up
Macroeconomic uncertainty among reasons driving PE investors to buy up more assets in the segment, long viewed as defensive
Add BT as a preferred source
[SINGAPORE] As private equity (PE) investors pour money into Asian healthcare, some observers are concerned that this sector could soon overheat.
Some recent deals this year include KKR’s US$400 million purchase of a 54 per cent stake in India’s Healthcare Global Enterprises in February. In Singapore, another American PE firm TPG took Catalist-listed nursing operator Econ Healthcare private in a deal worth nearly S$88 million. When the proposed transaction was announced in February, the offer price represented a 20 per cent premium to Econ’s last traded share price on Jan 14.
“We are not the only ones to see the opportunity of healthcare in Asia, and, as a consequence, valuations can be high,” Abrar Mir, co-founder and managing partner of healthcare-focused PE firm Quadria Capital, told The Business Times.
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
Is it time to scrap COE categories for cars?
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
Former manager with DBS Bank admits cheating 7 victims, including his uncle, of over S$1 million
